Megyn Kelly shared why she’s no longer in charge of cooking Thanksgiving dinner for her family after making an attempt three times, with each one just short of a “complete disaster.”

In the “American News Minute with Megyn Kelly” newsletter that came out on Friday, the host of “The Megyn Kelly Show” podcast talked about her disastrous attempts to cook the Turkey dinner, complete with sides, that ended one time with the bird catching “on fire.”

“I have tried to cook this meal three times,” Kelly explained. “The first, I was only second-in-command so it wasn’t a complete disaster. The next time was when [I] was single – I cooked for my sister and her kids at a little townhome I moved into during my early days at Fox. I forgot to take the turkey out of the freezer until Thanksgiving Day and learned the hard way, that’s too late.”

“The final attempt was when [husband] Doug and I tried to cook for our friends Lisa and John O’Hurley in New York City,” she added. “It was an unmitigated disaster. I inadvertently left half of my bags at the grocery store … all we had was turkey and stuffing. The turkey caught on fire and wound up as dry as Clark Griswold’s in Christmas Vacation.”

“We realized as we cooked that we were missing gravy, which — given the turkey situation — we really needed,” the former Fox News host continued, noting that at this point the only store open was a drugstore, with a packaged version. “While at first it seemed like an enormous watery soup, I soon found out that if you stir and stir and stir and stir the gravy gets thicker and actually … disappears…”

Things really got hilarious when Kelly shared how some “turkey grease” ended up getting on one of their dogs, leading the other dog to begin licking “the first dog incessantly for a week,” which the first dog “did not appreciate.”

This final Turkey Day attempt ended up with smoke billowing “out of the kitchen following the oven fire, O’Hurley yelled out, ‘I’ve got Jean-Georges on speed dial!’ In the end we opted not to dine at this five-star restaurant (mistake) and our dear friends never complained about their one-star holiday meal. But that was it for me.”

At the end of the letter, the podcast host shared how this year was the family’s first Thanksgiving without her sister Suzanne. Kelly shared that even though it was hard, she and her family, complete with her mom and her sister’s kids, enjoyed spending time together, reminding her “that what comes after tragedy is usually resilience.”

Related: Megyn Kelly Breaks Down On Air After Sharing Major Accident That Left Her Kid In ICU

The Food and Drug Administration (FDA) approved a $3.5 million drug treatment Tuesday, the most expensive drug in the world.

Hemgenix, manufactured by CSL Behring, is the first gene therapy that treats adults with hemophilia B, a genetic bleeding disorder resulting in insufficient levels of a protein called Factor IX that is needed to stop bleeding. Those with severe hemophilia B are required to have regular infusions, but the new multi-million dollar gene therapy is a single-dose IV infusion, carrying a gene for blood clotting Factor IX.

“Today’s approval provides a new treatment option for patients with Hemophilia B and represents important progress in the development of innovative therapies for those experiencing a high burden of disease associated with this form of hemophilia,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.

Around one in 40,000 people, mostly men, have the bleeding disorder. Those with hemophilia B can experience heavy or prolonged bleeding after injuries, surgeries, and dental procedures. Some with the hemophilia B even bleed for no apparent reason, and the disease can cause bleeding into joints, muscles, internal organs, and the brain.

“While the price is a little higher than expected, I do think it has a chance of being successful because 1) existing drugs are also very expensive and 2) hemophilia patients constantly live in fear of bleeds,” Brad Loncar, a biotechnology investor and chief executive officer of Loncar Investments, told Bloomberg. “A gene therapy product will be appealing to some.”

Hemgenix “consists of a viral vector carrying a gene for clotting Factor IX. The gene is expressed in the liver to produce Factor IX protein, to increase blood levels of Factor IX and thereby limit bleeding episodes,” the FDA explained.

The newly-approved drug has been in the works for over 20 years, and the agency approved it after “two studies of 57 adult men 18 to 75 years of age with severe or moderately severe Hemophilia B.”

Sitting at $3.5 million, Hemgenix is now the most expensive drug in the world, according to the Institute for Clinical and Economic Review, CNN reported. CSL Behring revealed the drug’s price tag shortly after the FDA approved it. Hemgenix topped Novartis’ Zolgensma gene therapy for spinal muscular atrophy (SMA) which sits at $2 million for a single-dose treatment.